M-TACE Treatment for Unresectable Hepatocellular Carcinoma
NCT05875558 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2023-05-25
Summary
This study aims to investigate the safety and efficacy of transarterial chenmoembolization（TACE） combined with microspheres for unresectable hepatocellular carcinoma(HCC).
Conditions
Interventions
- PROCEDURE
-
M-TACE
Lipiodol combined with microspheres
Sponsors & Collaborators
-
Shanghai Zhongshan Hospital
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-07-01
- Primary Completion
- 2023-12-01
- Completion
- 2024-07-01
Countries
- China
Study Locations
More Related Trials
-
TACE as an Adjuvant Therapy After Radiofrequency Ablation (RFA) for Hepatocellular Carcinoma
NCT00556803 ·Status: UNKNOWN ·Phase: PHASE4
-
Drug-eluting Bead Transarterial Chemoembolisation (DEB-TACE) Versus (VS) Conventional Transarterial Chemoembolisation (cTACE) for Unresectable Hepatocellualr Carcinoma (HCC)
NCT03969576 ·Status: UNKNOWN ·Phase: NA
-
Efficacy Study of TACE to Treat Hepatocellular Carcinoma After Operation
NCT02631499 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of TACE in Combination With ICIs for HCC: a Real-world Study
NCT04975932 ·Status: COMPLETED
-
TACE Plus Tegafur Versus TACE for Intrahepatic Cholangiocarcinoma After Curative Resection
NCT02588755 ·Status: UNKNOWN ·Phase: NA
-
Transcatheter Arterial Chemoembolization With KMG Microsphere Treating Advance-stage Hepatocellular Carinomas (TACE-KMG)
NCT01393197 ·Status: UNKNOWN ·Phase: NA
-
TACE Combined With Lenvatinib for Unresectable Hepatocellular Carcinoma
NCT04490694 ·Status: UNKNOWN ·Phase: PHASE2
-
Different Regimens of Transarterial Chemoembolization for Hepatocellular Carcinoma
NCT00493402 ·Status: COMPLETED ·Phase: PHASE3
-
Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using TACE With Antiangiogenesis
NCT00518557 ·Status: UNKNOWN ·Phase: NA
-
The Safety and Efficacy of Transarterial Chemoembolization (TACE) + Lenvatinib + Programmed Cell Death Protein 1 (PD-1) Antibody of Advanced Unresectable Hepatocellular Carcinoma
NCT04997850 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Cytoreductive Surgery and Transarterial Chemoembolization (TACE) Versus TACE for Hepatocellular Carcinoma
NCT00820157 ·Status: COMPLETED ·Phase: NA
-
TACE Plus Recombinant Human Adenovirus for Hepatocellular Carcinoma
NCT01869088 ·Status: UNKNOWN ·Phase: PHASE3
-
Lipiodol-TACE With Idarubicin Based On a Specific Emulsion Ratio for Hepatocellular Carcinoma
NCT05631613 ·Status: UNKNOWN
-
TACE Plus PD-1 Antibody vs TACE Alone for Unresectable HCC
NCT03782831 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Trial of Adjuvant Transarterial Chemoembolization (TACE) for Preventing Tumor Recurrence After Liver Resection
NCT00820053 ·Status: COMPLETED ·Phase: PHASE2
-
Liver Resection Versus Transarterial Chemoembolization for the Treatment of Intermediate-stage Hepatocellular Carcinoma
NCT02755311 ·Status: UNKNOWN ·Phase: PHASE3
-
Transarterial Chemoembolization (TACE) Therapy of Hepatocellular Carcinoma (HCC) With Blocking Tumor Blood Temporarily and Enhancing Perfusion
NCT00826384 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of TAC-101 in Combination With TACE Versus TACE Alone in Asian Patients With Advanced Hepatocellular Carcinoma
NCT00756782 ·Status: WITHDRAWN ·Phase: PHASE2
-
Effect of Tumor Micronecrosis on Postoperative Transcatheter Arterial Chemoembolization in Patients With Hepatocellular Carcinomas
NCT05352204 ·Status: COMPLETED
-
T-ACE Oil by TAE/TACE in Patients With Hepatocellular Carcinoma
NCT05435014 ·Status: SUSPENDED ·Phase: PHASE1/PHASE2
-
A Comparative Study of the Efficacy of Transcatheter Arterial Chemoembolization (TACE) and Transcatheter Arterial Pegylated Interferon Embolization (TAIE) for Liver Cancer
NCT00563095 ·Status: UNKNOWN ·Phase: NA
-
TACE Combined With Bevacizumab in HCC (BCLC-B) Beyond Up-To-Seven Criteria
NCT05883176 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy of Sequential TACE and PVE on the Resectability of Hepatitis B Related HCC
NCT00834158 ·Status: COMPLETED ·Phase: NA
-
Prospective Collection of Therapeutic Efficacy and Safety Data in Patients with Unresectable Hepatocellular Carcinoma
NCT06788353 ·Status: RECRUITING
-
A Phase III Randomized Study of TACE Plus an Oral Triple-Agent Cocktail Versus TACE Plus First-Line Targeted Immunotherapy in Unresectable Hepatocellular Carcinoma
NCT07309419 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3